Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease [2]

European Respiratory Journal

Volumn 20, Issue 1, 2002, Pages 243-244

  Miravitlles, M ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; THEOPHYLLINE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; COMPARATIVE STUDY; NOTE; STATISTICS;

COMPARATIVE STUDY; HUMAN; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; HUMANS;

EID: 0035989407     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.01302001     Document Type: Letter

References (9)

1. Geographical variations in prevalence and under-diagnosis of COPD. Results of the IBERPOC multicentre epidemiological study
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary
3. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
4. Treatment of chronic obstructive pulmonary disease and its exacerbations in General Practice
5. Tratamiento de la bronquitis crónica y la EPOC en Atención Primaria
6. Treatment and quality of life in patients with chronic obstructive pulmonary disease
7. Prehospitalization inhaled corticosteroid use in patients with COPD and asthma
8. Quality of life changes in COPD patients treated with salmeterol
9. Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995